BNXTF
Price
$0.61
Change
-$0.02 (-3.17%)
Updated
Sep 26 closing price
Capitalization
72.33M
SDZXF
Price
$60.08
Change
-$0.22 (-0.36%)
Updated
Sep 11 closing price
Capitalization
25.16B
32 days until earnings call
Interact to see
Advertisement

BNXTF vs SDZXF

Header iconBNXTF vs SDZXF Comparison
Open Charts BNXTF vs SDZXFBanner chart's image
BIONXT SOLUTIONS
Price$0.61
Change-$0.02 (-3.17%)
Volume$15.95K
Capitalization72.33M
Sandoz Group AG
Price$60.08
Change-$0.22 (-0.36%)
Volume$125
Capitalization25.16B
BNXTF vs SDZXF Comparison Chart in %
Loading...
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDZXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNXTF vs. SDZXF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNXTF is a Hold and SDZXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (BNXTF: $0.61 vs. SDZXF: $60.08)
Brand notoriety: BNXTF and SDZXF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BNXTF: 298% vs. SDZXF: 42%
Market capitalization -- BNXTF: $72.33M vs. SDZXF: $25.16B
BNXTF [@Pharmaceuticals: Generic] is valued at $72.33M. SDZXF’s [@Pharmaceuticals: Generic] market capitalization is $25.16B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNXTF’s FA Score shows that 0 FA rating(s) are green whileSDZXF’s FA Score has 0 green FA rating(s).

  • BNXTF’s FA Score: 0 green, 5 red.
  • SDZXF’s FA Score: 0 green, 5 red.
According to our system of comparison, SDZXF is a better buy in the long-term than BNXTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNXTF’s TA Score shows that 3 TA indicator(s) are bullish while SDZXF’s TA Score has 4 bullish TA indicator(s).

  • BNXTF’s TA Score: 3 bullish, 6 bearish.
  • SDZXF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SDZXF is a better buy in the short-term than BNXTF.

Price Growth

BNXTF (@Pharmaceuticals: Generic) experienced а +4.24% price change this week, while SDZXF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

SDZXF is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SDZXF($25.2B) has a higher market cap than BNXTF($72.3M). BNXTF YTD gains are higher at: 140.834 vs. SDZXF (45.855). SDZXF has higher annual earnings (EBITDA): 1.05B vs. BNXTF (-4.93M). SDZXF has more cash in the bank: 1.39B vs. BNXTF (4.24K). BNXTF has less debt than SDZXF: BNXTF (7.06M) vs SDZXF (5.69B). SDZXF has higher revenues than BNXTF: SDZXF (10.6B) vs BNXTF (21.7K).
BNXTFSDZXFBNXTF / SDZXF
Capitalization72.3M25.2B0%
EBITDA-4.93M1.05B-0%
Gain YTD140.83445.855307%
P/E RatioN/A115.53-
Revenue21.7K10.6B0%
Total Cash4.24K1.39B0%
Total Debt7.06M5.69B0%
TECHNICAL ANALYSIS
Technical Analysis
BNXTFSDZXF
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
43%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
64%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
38%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
48%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDZXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TEX51.811.18
+2.33%
Terex Corp
MDB318.413.09
+0.98%
MongoDB
WLKP20.950.18
+0.87%
Westlake Chemical Partners LP
AMST3.150.01
+0.32%
Amesite
GNLX4.20-0.01
-0.24%
Genelux Corp

BNXTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNXTF has been loosely correlated with DRRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if BNXTF jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
-4.37%
DRRX - BNXTF
62%
Loosely correlated
N/A
HLBBF - BNXTF
27%
Poorly correlated
N/A
PAHC - BNXTF
26%
Poorly correlated
+2.02%
SDZXF - BNXTF
24%
Poorly correlated
N/A
AMPH - BNXTF
24%
Poorly correlated
+1.86%
More

SDZXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SDZXF has been loosely correlated with SDZNY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SDZXF jumps, then SDZNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDZXF
1D Price
Change %
SDZXF100%
N/A
SDZNY - SDZXF
45%
Loosely correlated
+0.93%
BNXTF - SDZXF
26%
Poorly correlated
-4.37%
AGYTF - SDZXF
20%
Poorly correlated
N/A
CBSTF - SDZXF
7%
Poorly correlated
-1.12%
BLMH - SDZXF
3%
Poorly correlated
N/A
More